EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

First VIM-producing representative of Pseudomonas putida group from the largest Bulgarian hospital

Atanaska Petrova iD, Ivan N Ivanov iD, Liubomir Paunov, Angel Uchikov, Ivan Stoikov iD, Todor Kantardjiev, Marianna Murdjeva

Folia Medica · 2024

DOI: 10.3897/folmed.66.e129478 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Folia Medica, 2024. Verfasst von Atanaska Petrova und 6 weiteren Autor:innen. Beteiligte Einrichtung: Medical University of Plovdiv, Plovdiv, Bulgaria. Hauptthemen laut MEDLINE: beta-Lactamases. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Here we describe the first detected VIM-2-producing representative of Pseudomonas putida group – Pseudomonas kurunegalensis from the largest Bulgarian hospital – St George University Hospital in Plovdiv. A 59-year-old female patient with right-sided lung abscess was hospitalized in the Second Clinic of Thoracoabdominal Surgery. She was repeatedly treated for pulmonary infections. Punctate from the abscess cavity was taken for microbiological investigation. Identification process and antimicrobial susceptibility were performed by Vitek 2. The species group P. putida was confirmed with MALDI-TOF system and whole genome sequencing defined it as P. kurunegalensis . Antibiotic susceptibility testing revealed susceptibility only to tobramycin and colistin. All phenotypic tests for carbapenemase and metallo-beta-lactamase (MBL) production were positive. Multiplex PCR was performed to search for nine common carbapenemase encoding genes whereas the variable region of the integron was determined by DNA sequencing. Molecular assays confirmed the presence of blaVIM-2 located within a typical Class I integron including also an aacA29b aminoglycoside N(6’)-acetyltransferase casette. Despite P. putida not being a common pathogen, it still could survive in hospital conditions causing difficult-to-treat infections and becoming a source of resistant genes, including MBL-encoding genes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

beta-LactamasesBulgariaHumansPseudomonas putidaPseudomonas InfectionsAnti-Bacterial AgentsMicrobial Sensitivity Tests

Stichwörter der Autor:innen

extensively drug resistance lung abscess P. putida group P. kurunegalensis VIM-…

Substanzen

beta-Lactamasesbeta-lactamase bla(vim-2)Anti-Bacterial Agents

Autor:innen und Institutionen

  • Medical University of Plovdiv, Plovdiv, Bulgaria.
  • NCIPD-Sofia, Sofia, Bulgaria.

ORCID-Profile: Atanaska Petrova, Ivan N Ivanov, Ivan Stoikov

Zitieren

APA

Petrova, A., Ivanov, I. N., Paunov, L., Uchikov, A., Stoikov, I., Kantardjiev, T., & Murdjeva, M. (2024). First VIM-producing representative of Pseudomonas putida group from the largest Bulgarian hospital. Folia Medica. https://doi.org/10.3897/folmed.66.e129478

Vancouver

Petrova A, Ivanov IN, Paunov L, Uchikov A, Stoikov I, Kantardjiev T, et al. First VIM-producing representative of Pseudomonas putida group from the largest Bulgarian hospital. Folia Medica. 2024. doi:10.3897/folmed.66.e129478

BibTeX
@article{Petrova2024,
  author = {Petrova, Atanaska and Ivanov, Ivan N and Paunov, Liubomir and Uchikov, Angel and Stoikov, Ivan and Kantardjiev, Todor and Murdjeva, Marianna},
  title = {First VIM-producing representative of Pseudomonas putida group from the largest Bulgarian hospital},
  journal = {Folia Medica},
  year = {2024},
  doi = {10.3897/folmed.66.e129478}
}
Kostenlos starten →